UnitedHealth Pays Itself $151 Billion a Year. That's the Whole Machine — and the Whole Risk.
UnitedHealth's insurer arm steers patients to doctors UnitedHealth owns, then pays itself. In 2024 that internal traffic produced $150.9B in eliminations. The same loop that proves deep integration is now the DOJ's antitrust exhibit A.
Comes with a free Cross-Subsidy Map template — plus a worked example for UnitedHealth.
A patient with a UnitedHealthcare card sees a doctor, fills a prescription, gets sent home with a nurse, and somewhere in that chain a check changes hands. Here is the strange part: in a growing share of cases, the insurer paying the check and the clinic cashing it are the same company. UnitedHealth's care arm, Optum, sees more than 123 million consumers; the insurer covers nearly 50 million.4 When the two transact, UnitedHealth is, in effect, paying itself. Do that enough and the internal traffic is staggering: $150.9 billion of payments between segments in 2024, erased on the way to the income statement.3 That number isn't an accounting footnote. It's the entire business model, written in the one place the company can't hide it — its own SEC filing.
The official story is that UnitedHealth is a health insurer that happens to own some clinics. The truer story is that it is a vertically integrated machine designed so the insurer can route patients to doctors, pharmacies, and home-health agencies it also owns — and capture the spending on both sides of the visit. The DOJ now calls it, in a federal filing, 'a vertically integrated healthcare behemoth and the fifth-largest company in the United States.'7
The flywheel: insure the patient, then own where they go
The mechanism is simple to state and hard to copy. UnitedHealthcare collects premiums and decides which doctors are 'in network.' Optum owns the doctors. So the insurer can steer a covered member toward a clinic the parent company owns, and the money the insurer spends on care becomes Optum's revenue. The more members UnitedHealthcare signs up, the more patients flow to Optum; the more clinics Optum owns, the more attractive the insurer's network looks. It compounds. Optum's revenue hit $253 billion in 2024, up 12%, with Optum Health — the doctor-and-clinic arm — the fastest-growing piece, driven by value-based care.32 And value-based care is the quiet engine here: when UnitedHealth gets paid a fixed amount per patient and also owns the clinic treating them, every dollar of care it can deliver cheaply in-house drops to its own bottom line.
This is why the headline 'Optum employs 90,000 doctors' is both impressive and wrong. CEO Andrew Witty told Congress in May 2024 that Optum directly employs 'just under 10,000' physicians; the other roughly 80,000 are affiliated or contracted.5 The distinction is the whole game. Direct employment is the tight version of the flywheel — the parent can route patients and set economics. Affiliation is the loose version. The popular number flatters the integration by a factor of nine, but even the real number, growing by tens of thousands of affiliated clinicians a year, builds a network no standalone insurer can match.5
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| UnitedHealth total revenue | $371.6B | $400.3B | $447.6B |
| Optum revenue | $226.6B | $253B | $270.6B |
| Corporate intercompany eliminations | $136.4B | $150.9B | — |
| Net / operating margin signal | — | — | 2.7% net margin |
Why the same eliminations that prove integration also indict it
Here is the trap the model walked into. Those $150 billion of intercompany dollars are not hidden profit — under GAAP they're eliminated in consolidation, so they never inflate net income. The company's own filings disclose them line by line.13 But disclosure isn't the regulator's worry. The worry is the price at which the insurer pays its own doctors. The Affordable Care Act caps the share of premiums an insurer can keep as profit by mandating a minimum medical-loss ratio — most premium dollars must go to medical care. If you must spend 85 cents of every premium dollar on 'care,' and you own the company you're paying for that care, you can satisfy the rule by paying yourself generously. The cost counts as care; the profit reappears inside Optum. The cap stops bending revenue. It cannot stop money that walks across the hallway.
For years that was a theory. In 2025 it got a number. A peer-reviewed Health Affairs study, using CMS price-transparency data, found UnitedHealthcare pays Optum providers 17% more than rivals pay comparable non-Optum providers — and in markets where UnitedHealthcare holds 25%-plus share, the premium balloons to 61%.8 The authors named the two mechanisms a regulator dreams of: medical-loss-ratio gaming and the partial foreclosure of independent physicians. For a vertical-integration cross-subsidy, that is the smoking gun — paid-up internal prices that lift 'medical costs' while squeezing the doctors you don't own.
“A vertically integrated healthcare behemoth and the fifth-largest company in the United States, with revenues of $372 billion in 2023.”7
The honest counter: thin sample, thin margins, real efficiency
The fair objection is that the cross-subsidy case is tidier than the evidence. UnitedHealth's rebuttal to the Health Affairs study has teeth: the UHC-to-Optum observations were less than 0.2% of the full CMS dataset, drawn from a narrow set of billing codes — a small, cherry-pickable slice, the company argues, not a systemic readout.8 That's a real limitation, not a deflection, and an honest reader has to hold it. There's a second counter, too. A company that paid itself lavishly to game the MLR should be fat with profit, and UnitedHealth isn't: 2025 net margin was 2.7%, and the full year carried approximately $2.5 billion in restructuring and related charges (pre-tax), part of a broader $2.8 billion total charge that also encompassed cyberattack costs and divestiture expenses.10 When you own the risk and the care, you also own the losses. The flywheel can spin backward.
But notice what the steelman concedes. A 2.7% net margin on $447.6 billion of revenue is still a colossal absolute profit, and the integration threw off $19.7 billion of operating cash flow in 2025 — 1.5 times net income — on $447.6 billion of revenue.10 The model doesn't need a fat percentage; it needs scale and internal traffic, and it has both in quantities no rival approaches. The thin sample weakens the 17% as proof. It doesn't weaken the $150.9 billion of intercompany flow, which is documented, GAAP-audited, and growing — and that is the real structural fact regulators are circling.
Vertical integration is most powerful exactly where it's most exposed. When a company sits on both ends of a payment — the insurer paying, the clinic billing — the efficiency is real and so is the conflict, and the same disclosure that proves the integration (here, $150B+ in eliminations) hands a regulator the map. The lesson for any integrated operator: internal prices are not invisible just because they net to zero in consolidation. The moment a price cap, a fiduciary duty, or an antitrust theory attaches to the <em>cost</em> side, your intercompany terms become evidence. Build the flywheel — but assume every internal price will one day be read aloud in court.
UnitedHealth built the most complete machine in American healthcare: an insurer that decides where patients go, and a care arm that owns where they land. The genius was never a clever fee or a hidden margin. It was standing on both sides of the same transaction, so that money spent on care and money earned from care became the same money, moving across a hallway. That design produced $447.6 billion in revenue and the fifth-largest company in the country.47 It also produced the one liability you can't restructure away: a paper trail proving exactly how integrated you are. The company spent two decades building a loop nobody could route around — and is now discovering that the loop is also the evidence.
Cross-Subsidy Map
A map of the hidden plumbing inside a multi-line business: the cash-cow donor, the loss-making recipient it props up, and the strategic reason the subsidy exists. Use it to see who is really paying for what, and how exposed the whole structure is if the donor weakens. Blank to map your own portfolio's internal transfers; filled as the worked example of a business where one line secretly carries another.
The worked example unlocks with a subscription. See plans →
Sources
Where this comes from — the filings, records, and reporting behind it.
- 1UnitedHealth Group FY2023 total revenues were $371.6B; FY2023 medical costs were $241.9B; FY2023 operating costs were $54.6B. Corporate intercompany eliminations in 2023 were $136.4B and Optum eliminations were $3.7B.
- 2Optum full-year 2023 revenues were $226.6B (up 24% YoY) and operating earnings were $15.9B (up 13.4%). Optum Health revenue grew 33.9%, driven by value-based care expansion. Optum segment operating earnings: Optum Health $6.56B, Optum Insight $4.27B, Optum Rx $5.12B.
- 3UnitedHealth Group FY2024 total revenues were $400.3B (up 8% YoY). UnitedHealthcare revenues were $298.2B. Optum full-year 2024 revenues reached $253B (up 12%). Corporate intercompany eliminations in 2024 were $150.9B and Optum eliminations were $4.4B. Cash flows from operations were $24.2B (1.6x net income). The company returned over $16B to shareholders.
- 4UnitedHealth Group FY2025 consolidated revenues were $447.6B (up 12% YoY). UnitedHealthcare revenues grew 16% to $344.9B serving 49.8M consumers. Optum revenues grew 7% to $270.6B serving 123M+ consumers. Earnings from operations were $19.0B; net margin 2.7%. Q4 2025 restructuring charges totaled $2.5B including a $623M value-based care loss contract reserve.
- 5At UnitedHealth Group's November 29, 2023 investor conference, Optum Health CEO Amar Desai stated Optum has nearly 90,000 employed or affiliated physicians and 40,000 advanced practice clinicians. This compares to ~70,000 employed or affiliated at end of 2022—approximately 20,000 net additions in 2023. However, CEO Andrew Witty testified to Congress in May 2024 that Optum directly employs 'just under 10,000' physicians; ~80,000 more are affiliated.
- 6DOJ opened an antitrust investigation into UnitedHealth Group's Optum subsidiary in February 2024, focusing on whether UnitedHealthcare steered insurance members to Optum-owned practices and whether Optum's acquisition of physician offices was creating anticompetitive effects. By October 2025, the DOJ escalated to filing an omnibus antitrust lawsuit. A mid-2025 Amedisys settlement required UnitedHealth to divest 100+ home health locations to VitalCaring Group before the $3.3B deal could close.
- 7DOJ's August 2025 Federal Register filing in the Amedisys consent decree describes UnitedHealth as 'a vertically integrated healthcare behemoth and the fifth-largest company in the United States, with revenues of $372 billion in 2023.' It also documents that UnitedHealth acquired LHC Group for $5.4B in February 2023, folding it into Optum Health, and that LHC itself had acquired 44 home health/hospice companies across 20+ states from 2020 to 2023.
- 8A peer-reviewed Health Affairs study (2025) using CMS machine-readable price-transparency data found UnitedHealthcare pays Optum providers 17% more than competitors pay comparable non-Optum providers; in markets where UHC holds 25%+ market share, the premium rises to 61%. Authors flagged potential MLR gaming and partial foreclosure risks. UnitedHealth disputed the findings, citing small sample size: UHC-to-Optum observations represented less than 0.2% of the full dataset. The study was funded by Arnold Ventures and the Commonwealth Fund.
- 9By October 2025, the DOJ moved from investigation to filing an omnibus antitrust lawsuit targeting the core of UnitedHealth's vertical structure.
- 10UnitedHealth Group full year 2025 cash flows from operations were $19.7 billion, or 1.5x net income. Full year 2025 earnings from operations were $19.0 billion and net margin was 2.7%. The full year 2025 charge included restructuring and other of $2,521 million (pre-tax), with a total pre-tax impact of $2.878 billion.